| RRC ID |
66887
|
| 著者 |
Good ML, Vizcardo R, Maeda T, Tamaoki N, Malekzadeh P, Kawamoto H, Restifo NP.
|
| タイトル |
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells.
|
| ジャーナル |
J Vis Exp
|
| Abstract |
The generation and expansion of functional T cells in vitro can lead to a broad range of clinical applications. One such use is for the treatment of patients with advanced cancer. Adoptive T cell transfer (ACT) of highly enriched tumor antigen-specific T cells has been shown to cause durable regression of metastatic cancer in some patients. However, during expansion, these cells may become exhausted or senescent, limiting their effector function and persistence in vivo. Induced pluripotent stem cell (iPSC) technology may overcome these obstacles by leading to in vitro generation of large numbers of less differentiated tumor antigen-specific T cells. Human iPSC (hiPSC) have the capacity to differentiate into any type of somatic cell, including lymphocytes, which retain the original T cell receptor (TCR) genomic rearrangement when a T cell is used as a starting cell. Therefore, reprogramming of human tumor antigen-specific T cells to hiPSC followed by redifferentiation to T cell lineage has the potential to produce rejuvenated tumor antigen-specific T cells. Described here is a method for generating tumor antigen-specific CD8αβ+ single positive (SP) T cells from hiPSC using OP9/DLL1 co-culture system. This method is a powerful tool for in vitro T cell lineage generation and will facilitate the development of in vitro derived T cells for use in regenerative medicine and cell-based therapies.
|
| 巻・号 |
(152)
|
| 公開日 |
2019-10-24
|
| DOI |
10.3791/59997
|
| PMID |
31710026
|
| MeSH |
Cell Differentiation
Humans
Induced Pluripotent Stem Cells / metabolism*
T-Lymphocytes / metabolism*
|
| IF |
1.163
|
| リソース情報 |
| ヒト・動物細胞 |
OP9/N-DLL1(RCB2927) |
